Scrip dividend declaration

RNS Number : 5052Z

Assura PLC

13 January 2020

 

13 January 2020

Assura plc

Scrip Dividend Declaration

Assura plc ("Assura" or "the Company"), the UK's leading primary care property investor and developer, today announces that, pursuant to its Scrip Dividend Scheme and in response to the scrip dividend alternative for the quarterly interim dividend payable on 15 January 2020 (the "Scrip Dividend Alternative"), elections were received in respect of 12 per cent. of the Company's ordinary shares in issue as at the record date of 13 December 2019.

Electing shareholders will receive ordinary shares in the Company ("Shares") in lieu of cash in respect of this dividend and, accordingly 2,695,039 Shares (the "New Shares") will be issued by the Company to such shareholders.

Application has therefore been made for the admission of the New Shares to the Official List of the UK Listing Authority and to trading on the London Stock Exchange's market for listed securities ("Admission"). The New Shares will rank pari passu with the Company's existing ordinary shares and Admission is expected to occur at 8.00am on 15 January 2020.

Following the allotment of the New Shares, it is expected that the total number of shares in issue will be 2,413,241,827 (none of which will be held in treasury) and that, accordingly, the total number of voting rights of the Company will be 2,413,241,827.

Copies of the documents relating to the Scrip Dividend Alternative are available for inspection through the National Storage Mechanism (http://www.morningstar.co.uk/uk/NSM).

This interim dividend is 100% Ordinary Dividend (Non-PID).

Forms to register for gross PIDs (on future interim dividends) are available on the Company's website. Please click here for PID Forms.

-ENDS-

For more information, please contact:

Assura plc	Tel: [phone]
Orla Ball, Company Secretary David Purcell, Head of Financial Reporting
Finsbury Gordon Simpson James Thompson	Tel: [phone]

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 30 September 2019, Assura's property portfolio was valued at £2,039 million.

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association
Assura plc LEI code: 21380026T19N2Y52XF7

 

END

 

 

DIVKZGMMVGRGGZM